Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Global Hodgkin’s Lymphoma Market - 2023-2030
... Hodgkin’s lymphoma market is expected to exhibit a CAGR of 9.8% during the forecast period (2023-2030). The increasing technological advancements and the growing investments in novel products are driving up demand for Hodgkin’s lymphoma market ... Read More
-
Global Non-Hodgkin Lymphoma Market - 2023-2030
... non-Hodgkin lymphoma market is expected to exhibit a CAGR of 8.2% during the forecast period (2023-2030). The NHL market has witnessed a notable emphasis on the development and commercialization of targeted therapies. Biomarker identification and ... Read More
-
Global Breast Cancer Drugs Market Market - 2023-2030
... 2030. The Global Breast Cancer Drugs Market is expected to exhibit a CAGR of 9.2% during the forecast period 2023-2030. The increasing demand for discovering novel therapies and optimizing existing treatments are driving up demand ... Read More
-
Global Bone Cancer Market - 2023-2030
... Bone Cancer Market is expected to exhibit a CAGR of 4.8% during the forecast period 2023-2030. Bone cancer can begin in any bone in the body, but it most commonly affects the pelvis or the ... Read More
-
Pharmacogenomics Market by Technology (Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others), Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others), and End User (Hospitals & Clinics, Research Institutions and Academic Institutes and Others): Analysis and Industry Forecast, 2027
... Institutions and Academic Institutes and Others): Analysis and Industry Forecast, 2027 The pharmacogenomics market refers to the market for diagnostic tests and technologies used to study an individual's genetic makeup and how it affects their ... Read More
-
Myelofibrosis Treatment Market by Type (Targeted therapy, Chemotherapy and Others), Distribution Channel (Hospital pharmacies, Retail and specialty pharmacies and Online pharmacies) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2027
... unusual type of blood cancer. The bone marrow becomes scarred, which makes it complicated to make blood cells. It belongs to a group of diseases referred as myeloproliferative disorders or myeloproliferative neoplasms. Stem cells are ... Read More
-
Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2027
... Analysis and Industry Forecast, 2027 The Natural Killer (NK) Cells Therapeutics market refers to the pharmaceutical products and therapies aimed at utilizing and enhancing the functions of natural killer cells for therapeutic purposes. Natural killer ... Read More
-
Non-Small Cell Lung Cancer Market by Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Others and Adenocarcinoma), Treatment Type (Chemotherapy, Targeted Therapy and Immunotherapy), Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy and Online Pharmacy) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027
... and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027 Non-small cell lung cancer is a form of lung cancer, where malignant tumor cells are formed in the lungs. It comprises of ... Read More
-
Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 14.7 Billion by 2028, exhibiting a growth rate (CAGR) of 21.6% during 2023-2028. Cancer is a lifestyle disease that occurs due to the abnormal growth of cells and may result in the formation ... Read More
-
Bronopol Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... US$ 1.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.8% during 2023-2028. Bronopol is a colorless, water-soluble organic compound, produced by the bromination of di(hydroxymethyl)-nitromethane. It is supplied as crystals or crystalline powder, ... Read More
-
Global Oncology Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029
... (2023-2029). This report studies the global Oncology Radiopharmaceutical production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive analysis of the world market for Oncology Radiopharmaceutical, and provides market size (US$ ... Read More
-
Global Oncology Radiopharmaceutical Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This ... Read More
-
Europe Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... Breast cancer is the leading form of cancer affecting women in Europe, with approximately 400,000 new cases annually and resulting in 100,000 fatalities. This type of cancer originates from malignant tumors that develop in breast ... Read More
-
United States Women Health Laboratory Testing Market By Hereditary Cancer (Cervical Cancer, Ovarian Cancer, Breast Cancer), By Reproductive Health and Infectious Diseases (CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By Prenatal Screening and Diagnostic Testing (Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), Prenatal Diagnostic Testing), By Region, Competition Forecast & Opportunities, 2018-2028
... Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By Prenatal Screening and Diagnostic Testing (Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), Prenatal Diagnostic Testing), By Region, Competition Forecast ... Read More
-
United States CAR-T Cell Therapy Market By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), Tecartus (Brexucabtagene Autoleucel), Breyanzi (Lisocabtagene Maraleucel), Abecma (Idecabtagene Vicleucel), Others), By Tumor Type (Hematological Malignancies, Solid Tumors), By Indication (Diffused Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2028.
... B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User ... Read More
-
United States Prostate Cancer Testing Market By Biomarker Type (Pre-Biopsy/Post-Negative Biopsy Testing, Initial Evaluation: Prostate-Specific Antigen (Total PSA, Free PSA), Post-Biopsy Tissue Testing), By Application (Diagnostics Biomarkers, Prognostics Biomarkers), By End User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals and Clinics, Ambulatory Surgical Center (ASCs), and Others), By Region, Competition Forecast & Opportunities, 2018-2028
... Diagnostic Laboratories, Hospitals and Clinics, Ambulatory Surgical Center (ASCs), and Others), By Region, Competition Forecast & Opportunities, 2018-2028 United States Prostate Cancer Testing Market is expected to grow at an impressive rate during the forecast ... Read More
-
Medullary Thyroid Cancer
... in the C cells of the thyroid gland. Unlike other types of thyroid cancer that arise from follicular cells, MTC is associated with the overgrowth of these C cells and the production of elevated levels ... Read More
-
Biliary Tract Cancers (BTCs)
... various factors, including the increasing prevalence and incidence of BTCs, advancements in diagnostic technologies, evolving treatment approaches, growing awareness and screening programs, collaborative research efforts, favorable reimbursement policies, and the growing geriatric population. Despite the ... Read More
-
2023 Global Forecast for Pet Cancer Therapeutics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
United States Nutrigenomics Market By Product & Services (Services (Nutrigenomics Genetic Testing) vs Product), By Product (Vitamins & Supplements, Probiotics, Prebiotics), By Technique (Saliva/Buccal Swab, Blood, Others), By Application (Obesity, Cancer Research, Cardiovascular Diseases, Digestive Health, Others) By Region, Competition, Forecast, and Opportunities, 2028F
... Health, Others) By Region, Competition, Forecast, and Opportunities, 2028F United States Nutrigenomics Market is expected to grow at a significant rate during the forecast period 2024-2028. The growing demand in the Nutrigenomics Market may be ... Read More
-
Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Chronic Myelomonocytic Leukaemia- Pipeline Insight, 2023
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Asia Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... Renub Research. Breast cancer stands as the prevailing cancer diagnosis among women and remains the primary cause of cancer-related fatalities in Asia. Breast cancer affects Asian women at an earlier age compared to their Western ... Read More
-
T cell Lymphoma -Pipeline Insight, 2023
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
Research Assistance
